#1 Clinical Trials Search in Europe

Interferon Gamma

Interferon Gamma, a powerful immune system regulator, is being investigated in various clinical trials for its potential to treat a wide range of conditions. From rare genetic disorders to common infections, researchers are exploring how this drug might improve patient outcomes by modulating the immune response and combating diseases in novel ways.

Table of Contents

What is Interferon Gamma?

Interferon gamma, also known as interferon gamma-1b, is a powerful regulatory protein naturally produced by our immune system. It plays a crucial role in activating our body’s defense mechanisms against various diseases[1]. In medical treatments, a synthetic version of this protein is used as a drug to boost the immune response and fight certain conditions.

This medication is known by several names, including:

Conditions Treated with Interferon Gamma

Interferon gamma is being studied and used to treat a variety of conditions, including:

  1. Friedreich’s Ataxia (FRDA): This is a genetic disorder that affects the nervous system and causes movement problems. Interferon gamma is being tested to see if it can increase the levels of a protein called frataxin, which is low in people with FRDA[3][2].
  2. Chronic Hepatitis C: This is a long-lasting viral infection that affects the liver. Interferon gamma is being studied as a potential treatment for patients who didn’t respond to other therapies[4].
  3. COVID-19: Researchers are investigating whether interferon gamma can help treat respiratory infections caused by the COVID-19 virus[1].
  4. Candidemia: This is a serious blood infection caused by a type of yeast called Candida. Interferon gamma is being tested as a potential treatment[5].
  5. Central Serous Chorioretinopathy (CSC): This is an eye condition where fluid builds up under the retina. Interferon gamma is being studied as a potential treatment to reduce this fluid buildup[6].
  6. Uveitis: This is an inflammation of the eye. Researchers are investigating whether interferon gamma can help reduce swelling in the eye caused by this condition[7].
  7. Autosomal Dominant Osteopetrosis Type 2 (ADO2): This is a rare genetic disorder that affects bone development. Interferon gamma is being studied as a potential treatment[8].

Administration Methods

Interferon gamma can be administered in several ways, depending on the condition being treated:

  • Subcutaneous injections: The medication is injected under the skin. This is the most common method for conditions like Friedreich’s Ataxia and chronic hepatitis C[3][4].
  • Eye drops: For eye conditions like central serous chorioretinopathy and uveitis, interferon gamma may be administered as eye drops[6][7].

Current Clinical Trials

Several clinical trials are currently underway to investigate the effectiveness of interferon gamma for various conditions:

  • A study is examining its potential to increase frataxin levels in patients with Friedreich’s Ataxia[3].
  • Another trial is testing its effectiveness in treating chronic hepatitis C in patients who didn’t respond to other treatments[4].
  • Researchers are investigating its use in treating COVID-19 respiratory infections[1].
  • A study is looking at its potential in treating candidemia (a blood infection)[5].
  • Two trials are examining its use in eye conditions: central serous chorioretinopathy and uveitis[6][7].

Potential Side Effects

Like all medications, interferon gamma can cause side effects. The most common side effects reported in clinical trials include:

  • Flu-like symptoms: This can include fever, chills, muscle aches, and tiredness[9].
  • Injection site reactions: If given as an injection, there may be redness, swelling, or pain at the injection site.
  • Eye irritation: When used as eye drops, it may cause temporary discomfort or irritation[6].

It’s important to note that not everyone experiences these side effects, and they often decrease over time as the body adjusts to the medication. Always discuss potential side effects with your healthcare provider before starting any new treatment.

Condition Trial Phase Administration Method Key Outcomes Measured
Friedreich’s Ataxia Phase 2 Subcutaneous injections Frataxin levels, neurological outcomes
Chronic Hepatitis C Pilot study Subcutaneous injections Viral RNA levels, T cell responses
Central Serous Chorioretinopathy Phase 1/2 Eye drops Visual acuity, retinal thickness
Ventilator-Associated Pneumonia Not specified Subcutaneous injections Duration of mechanical ventilation, mortality
Candidemia Phase 2 Subcutaneous injections Time to negative blood culture, overall survival
COVID-19 Not specified Subcutaneous injections Clinical improvement, laboratory values

FAQ

  • What is Interferon Gamma? Interferon Gamma is a naturally occurring protein in the body that plays a crucial role in regulating immune responses. In clinical trials, a synthetic version called Interferon Gamma-1b is being used as a potential treatment for various conditions.
  • What conditions are being studied with Interferon Gamma? Clinical trials are investigating Interferon Gamma for a diverse range of conditions, including Friedreich's Ataxia, chronic hepatitis C, central serous chorioretinopathy, ventilator-associated pneumonia, candidemia, and COVID-19.
  • How is Interferon Gamma administered in these trials? The administration method varies depending on the condition being treated. It can be given as subcutaneous injections, intramuscular injections, or even as eye drops in some cases. The dosage and frequency also differ between trials.
  • What are the potential benefits of Interferon Gamma treatment? Potential benefits being studied include increasing frataxin levels in Friedreich's Ataxia patients, enhancing antiviral responses in hepatitis C and COVID-19, improving fluid reabsorption in eye conditions, and boosting immune responses against fungal infections like candidemia.
  • Are there any side effects associated with Interferon Gamma treatment? Common side effects can include flu-like symptoms such as fever, chills, fatigue, and muscle aches. However, the severity and frequency of side effects can vary depending on the dosage and administration method. Some trials are specifically studying ways to reduce these side effects.

Ongoing Clinical Trials on Interferon Gamma

  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium

Glossary

  • Frataxin: A protein important for proper functioning of mitochondria (the cell's energy producers). Low levels of frataxin are associated with Friedreich's Ataxia.
  • Candidemia: A blood infection caused by Candida yeast species, which can be serious, especially in people with weakened immune systems.
  • Central Serous Chorioretinopathy (CSC): An eye condition where fluid builds up under the retina, potentially causing vision problems.
  • Ventilator-Associated Pneumonia (VAP): A lung infection that develops in people who are on mechanical ventilation breathing machines in hospitals.
  • Friedreich's Ataxia (FRDA): A rare genetic disease that causes progressive damage to the nervous system, resulting in movement problems, heart disease, and other issues.
  • HLA-DR: A protein found on the surface of certain immune cells, used as a marker of immune system activation.
  • Subretinal Fluid: Fluid that accumulates underneath the retina, which can cause vision problems in conditions like Central Serous Chorioretinopathy.
  • Immunotherapy: Treatment that uses certain parts of a person's immune system to fight diseases such as cancer, infections, or other conditions.

References

  1. https://clinicaltrials.gov/study/NCT05386459
  2. https://clinicaltrials.gov/study/NCT01965327
  3. https://clinicaltrials.gov/study/NCT02035020
  4. https://clinicaltrials.gov/study/NCT00028275
  5. https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-recombinant-human-interferon-gamma-1b-with-standard-therapy-for-patients-with-candidemia/
  6. https://clinicaltrials.gov/study/NCT01468337
  7. https://clinicaltrials.gov/study/NCT01376362
  8. https://clinicaltrials.gov/study/NCT02584608
  9. https://clinicaltrials.gov/study/NCT01929382